Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;278(5):1675-1685.
doi: 10.1007/s00405-020-06396-8. Epub 2020 Oct 3.

Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection

Affiliations

Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection

Müge Özçelik Korkmaz et al. Eur Arch Otorhinolaryngol. 2021 May.

Abstract

Purpose: The aim of our study is to evaluate the incidence and characteristics of otolaryngology symptoms in COVID 19 patients.

Methods: 116 patients with positive PCR test results for COVID-19 and followed up by otolaryngologists at a tertiary referral center/COVID-19 pandemic hospital were questioned in terms of otolaryngology symptoms associated with COVID-19 infection. Data including demographics, disease severity, concomitant diseases, previous otolaryngologic diseases,incidence and duration of new onset symptoms were collected and categorically analyzed. In addition, the severity of loss of smell and taste was evaluated by visual analogue score (VAS).

Results: A total of 58 men and 58 women participated. The mean age of the patients was 57.24 ± 14.32 (19-83). The most common otolaryngological findings were hyposmia/anosmia (37.9%) and hypogeusia/ageusia (41.37%), respectively. These complaints were followed by headache (37.1%), and nausea/vomiting (31%). The most common oropharyngeal symptoms were sore throat (32.7%) and dysphagia (20.6%). The rate of otological/vestibular symptoms was dizziness (31.8%), tinnitus (11%), true vertigo (6%), and hearing impairment (5.1%), respectively. The most of symptoms were more frequent in > 60 years and women. There was a significant correlation between nasal itching and smell disturbance in patients with allergic rhinitis. Considering the duration of symptoms, the longest were hyposmia/anosmia and hypogeusia/ageusia. The mean VAS's in patients with hyposmia/anosmia and hypogeusia/ageusia were 5.52 ± 2.08 and 5.79 ± 2.21, respectively.

Conclusion: The most common otolaryngologic symptoms of COVID-19 infection are known as sore throat, smell and/or taste disturbances. However, our study showed that these patients can be seen with different symptoms in otological or laryngeal areas. Therefore, a more careful evaluation should be made in terms of otolaryngologic symptoms when COVID 19 infection is suspected.

Keywords: Allergic rhinitis; COVID-19; Otology; Rhinology; Throat; Vertigo.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to report.

Figures

Fig. 1
Fig. 1
Distribution frequency of symptoms
Fig. 2
Fig. 2
Data on the maximum, minimum and median duration of the symptoms over a period of 30 days
Fig. 3
Fig. 3
Factor analysis with Promax rotation of the frequencies for the 19 questions related to otolaryngology in COVID 19 patients. The questions are divided into six different subgroups in relation to each other

Similar articles

Cited by

References

    1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Johns Hopkins University and Medicine (2020) Coronavirus resource center. https://coronavirus.jhu.edu/. (Accessed 16 Sept 2020).
    1. Zhang X, Chen X, Chen L, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18:360–362. doi: 10.1016/j.jtos.2020.03.010. - DOI - PMC - PubMed
    1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. doi: 10.1056/NEJMoa1211721. - DOI - PubMed
    1. Gilani S, Roditi R, Naraghi M. COVID-19 and anosmia in Tehran. Iran Med Hypotheses. 2020;141:109757. doi: 10.1016/j.mehy.2020.109757. - DOI - PMC - PubMed